Bendazac or 1-benzyl-indazole 3-oxyacetic acid is a topical antinflammatory drug which in previous experiments was shown to preferentially inhibit inflammatory processes progressing towards necrosis (1). This activity has been temptatively related to a pre vention of protein denaturation (2-4).
Burns were produced in rats by putting on the abdomen for 30 seconds a test tube (weighing 50 g and with a diameter of about 8 mm) in which water was circulated at a temperature of 70°C. In each animal two burns were produced, one on the upper third and the other on the lower third of the abdomen. Two minutes later, the burnt areas were rubbed gently with 2 ml of the creams under investigation. One hour later, the ani mals were intravenously injected with 1 ml of a water solution containing 0.5% Evans Blue and 0.9% NaC1. Two hours after application of the creams, animals were killed by a blow on the head and the burnt skin was stretched and inserted between two glass slides. The intensity of blueing, resulting from accumulation of Evans Blue in the injured skin, was estimated by a Joyce Loebl mod. II photodensitometer devised for automatic read ing of electrophoretic tracings.
Acetic acid erythema was studied in mice. A disc of filter paper, 4 mm in diameter, was soaked with glacial acetic acid and applied on the back of animals taking care that the paper adhered to the skin. After 15 seconds the disc was removed, the excess of acetic acid was wiped and a minute later 0.5 ml of the creams were applied locally. One hour later, the animals were intravenously injected with 0.5 ml of a water solution containing 0.1 % Evans Blue and 0.9 % NaC1. After 30 minutes animals were killed by a blow on the head and the skin of the back was examined in the same way as described for heat burns.
The urinary excretion of bendazac was studied in unanesthetized rats. Two ml of a cream containing bendazac were applied on the back skin of the animals. The area treated was covered with a gauze square which was fixed to the skin with elastoplast band age, thus establishing a waterproof cuff. Immediately after dressing, rats were placed in diuresis cages designed for separate collection of urine and faeces. Throughout the whole experiment the rats had free access to water, but were without food. After 18 hours, urine was collected and its contents in bendazac was determined according to a method already described (2) .
Acute local tolerance tests were performed on unanesthetized rats. By means of a glass splinter, 8 longitudinal scarifications of about 1.5 cm, regularly spaced, were carried out on the animals' trunk according to Draize indications (5). The whole scarified area was rubbed with I ml of cream, protected with gauze and wrapped with elastoplast band age fixed on the trunk of the animal. After 24 hours the dressing was removed and rats were examined. Examinations were repeated on the subsequent 2 days.
The drugs were blended in creams having the following formulation :
Type A: 0.6 g Sorbitan monostearate-4.4 g Polyoxyethylenesorbitan--monostearate 3 g Cetylstearyl alcohol-9 g Stearic acid-10 g Paraffin liquid-2 g Isopropyl miristate 6 g Glycerin-0.18 g Nipagin-0.02 g Nipasol-Water q.s. to 100 g-pH 5.5. Type B: 25 g Xalifin 15''t *-6 g Sorbitol 70 %-0.18 g Nipagin-0.02 g Nipasol-Water q.s. to 100 g-pH 5.9. Bendazac and hydrocortisone acetate were used in the highest concentration employed in medical practice. When necessary the pH of the creams was adjusted to the values reported above by means of NaOH. The control animals were treated with a cream containing only the excipients. Sig nificance of results was evaluated according to the Student's t method. In the case of heat burns and of acetic acid erythema, the photodensitometric values were transformed, before the statistic elaboration, in per cent values referring to the highest response ob tained in each experiment. Further details regarding this procedure may be found in a previous paper (1).
RESULTS
Results obtained by studying effects of bendazac and hydrocortisone on heat burns are summarized in Table 1 .
Bendazac and hydrocortisone were blended, at a 3 % concentration, in both type A and type B creams. Bendazac produced a significant protection only when blended in type B formulation, while hydrocortisone was inactive in both formulations. Results obtained by studying effects of bendazac and hydrocortisone, blended both in type A cream and type B cream, on the experimental erythema induced by acetic acid are reported in Table 2 . * Supplied by Croda LTD , Enaith Goole, England. Bendazac and hydrocortisone, the latter more effectively than the former, prevented the inflan-imation induced by acetic acid with both excipients.
The above mentioned experiments proved that the activity of bendazac on heat burns was substantially conditioned by the excipients. Therefore it was deemed useful to as certain whether absorption or local tolerance of the two examined preparations was dif ferent. Values of urinary excretion of bendazac after its applications on the skin are re ported in Table 3 .
The quantity of the drug excreted in the urine proved to be similar with both for mulations.
The acute tolerance tests were performed by comparing four formulations, represent ed by excipients type A and B respectively, with or without 3 % bendazac.
The most striking difference among the plain creams was observed 24 hours follow ing medication and consisted in an hematic exudation which was produced by the type A, but not by the type B excipients. The same difference among the type A and type B excipients was observed when bendazac was blended into them.
DISCUSSION
Previous experiments have shown that bendazac and hydrocortisone have super imposible antinflammatory effects only in conditions where the vascular response is pre minent, while the former is superior against necrotic responses, the latter is superior against proliferative responses (1) . Results of these experiments confirm that bendazac and hy drocortisone possess a different spectrum of effects. As a matter of fact heat-induced burns, which are a typical condition evolving toward necrosis, were inhibited by bendazac but not by hydrocortisone; on the other hand the response to acetic acid, which is ery thematous in its nature, was inhibited by both drugs though hydrocortisone proved to be more effective than bendazac.
On the basis of these results a potential therapeutic interest of bendazac in anti-burn therapy is suggested.
The quality of excipients appeared to be of critical importance with regard to the anti-burn activity of bendazac, which was effective in this test only when the cream con taining Xalifin 15© was used. This excipient did not change the absorption of the drug through the skin, but proved to be by itself better tolerated than the conventionally for mulated cream. These results suggest that the influence of excipients on the anti-burn activity of bendazac is related to the nature of burns, which involve a severe damage of the skin and probably a hypersensitivity to irritating stimuli; they also suggest that pre ference should be given in all clinical applications of bendazac, to creams containing Xali fin 158 instead of synthetic surfactants.
SUMMARY
The topical effects of 3 % bendazac and hydrocortisone on heat burns and on acetic acid-induced erythema in rats and mice were studied. Moreover a conventionally for mulated hydrophilic cream (type A) and a cream containing Xalifin 15© (type B) were compared. Bendazac inhibited acetic acid-induced erythema with both excipients, while its activity against heat burns was shown only by using type B excipients. Hydrocortisone was effective only against acetic acid-induced erythema and its activity was not influenced by excipients.
Urinary excretion of bendazac following application on the skin was similar with both excipients, while its topical tolerance was better with type B excipients than with type A excipients.
